4/21
08:45 am
ftre
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Medium
Report
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
4/14
08:57 am
ftre
Fortrea (FTRE) was given a new $11.00 price target by Barclays PLC.
Low
Report
Fortrea (FTRE) was given a new $11.00 price target by Barclays PLC.
4/7
07:00 am
ftre
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
Medium
Report
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
3/10
04:15 pm
ftre
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
3/9
09:00 am
ftre
Fortrea (FTRE) was upgraded by TD Cowen from "hold" to "buy". They now have a $15.00 price target on the stock.
Low
Report
Fortrea (FTRE) was upgraded by TD Cowen from "hold" to "buy". They now have a $15.00 price target on the stock.
2/27
10:38 am
ftre
Fortrea (FTRE) had its price target lowered by Barclays PLC from $15.00 to $12.00. They now have an "equal weight" rating on the stock.
Medium
Report
Fortrea (FTRE) had its price target lowered by Barclays PLC from $15.00 to $12.00. They now have an "equal weight" rating on the stock.
2/27
08:02 am
ftre
Fortrea (FTRE) had its price target lowered by Robert W. Baird from $19.00 to $16.00. They now have an "outperform" rating on the stock.
Low
Report
Fortrea (FTRE) had its price target lowered by Robert W. Baird from $19.00 to $16.00. They now have an "outperform" rating on the stock.
2/26
04:04 pm
ftre
Fortrea Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Fortrea Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
06:28 am
ftre
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance [Yahoo! Finance]
Medium
Report
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance [Yahoo! Finance]
2/26
06:00 am
ftre
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
Medium
Report
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
2/17
07:00 am
ftre
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Low
Report
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
1/29
08:08 am
ftre
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
Medium
Report
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call